In financial year 2021 in India, GSK Pharmaceuticals Limited spent approximately 32.7 million Indian rupees on projects relating to corporate social responsibility (CSR). The largest portion of this sum, 12.2 million rupees, was spent on projects to promote childhood nutrition.
Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited in India during financial year 2021, by project (in million Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic GSK Pharmaceuticals' CSR expenditure in India 2020 by project
- Premium Statistic GSK Pharmaceuticals' CSR expenditure in India 2020 by type
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' revenue share from operations in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' total income in India FY 2017-2023
- Premium Statistic GSK Pharmaceuticals' operation revenue in India FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' earnings per share in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' book value per share India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' market price of shares at NSE India FY 2023, by month
About the region
10
- Premium Statistic GSK Pharmaceuticals' profit before tax in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' share of income utilized in India 2023, by category
- Premium Statistic GSK Pharmaceuticals' net assets India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' shareholder distribution India FY 2023
- Premium Statistic GSK Pharmaceuticals' remuneration of executive directors in India 2023
- Premium Statistic GSK Pharmaceuticals' India equity share capital FY 2015-2023
- Premium Statistic Cipla's gross revenue FY 2015-2023
- Premium Statistic Cipla's BSE market price FY 2021-2023
- Premium Statistic Cipla's shareholders 2023, by type
Selected statistics
9
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
Other regions
10
- Premium Statistic Sino Biopharm net profit 2013-2022
- Premium Statistic Number of pharmacy actors in Sweden 2013-2022
- Basic Statistic Country comparison in spending on medicine 2026
- Premium Statistic Saudi Pharmaceutical Industries and Medical Appliances Corporation revenue 2012-2018
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Top pharmaceutical companies in Argentina 2014 by revenue
- Basic Statistic Distribution self-medication revenues Netherlands 2023, by purchase channel
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
- Basic Statistic Hungary: number of pharmaceutical preparations manufacturers 2013-2022
- Basic Statistic Turkey: number of pharmaceutical preparations manufacturers 2009-2014
Related statistics
10
- Premium Statistic Cipla's CSR expenditure 2020 by project
- Premium Statistic Cipla's SAGA revenue FY 2017-2018
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Cipla's API revenue FY 2017-2023
- Premium Statistic Cipla's EBITDA margin FY 2014-2023
- Premium Statistic Cipla's R&D investment share FY 2014-2023
- Premium Statistic Cipla's revenue share 2023, by medical therapy
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
Further related statistics
10
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Banco Santander global operations: geographic diversification of profit 2023
- Johnson & Johnson's number of employees 2004-2023
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Banco Santander global operations: geographic diversification of profit 2023
- Johnson & Johnson's number of employees 2004-2023
GlaxoSmithKline. (June 28, 2021). Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited in India during financial year 2021, by project (in million Indian rupees) [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1249474/india-gsk-pharmaceuticals-csr-expenditure/
GlaxoSmithKline. "Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited in India during financial year 2021, by project (in million Indian rupees)." Chart. June 28, 2021. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1249474/india-gsk-pharmaceuticals-csr-expenditure/
GlaxoSmithKline. (2021). Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited in India during financial year 2021, by project (in million Indian rupees). Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1249474/india-gsk-pharmaceuticals-csr-expenditure/
GlaxoSmithKline. "Corporate Social Responsibility Expenditure of Gsk Pharmaceuticals Limited in India during Financial Year 2021, by Project (in Million Indian Rupees)." Statista, Statista Inc., 28 Jun 2021, https://www.statista.com/statistics/1249474/india-gsk-pharmaceuticals-csr-expenditure/
GlaxoSmithKline, Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited in India during financial year 2021, by project (in million Indian rupees) Statista, https://www.statista.com/statistics/1249474/india-gsk-pharmaceuticals-csr-expenditure/ (last visited June 01, 2024)
Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited in India during financial year 2021, by project (in million Indian rupees) [Graph], GlaxoSmithKline, June 28, 2021. [Online]. Available: https://www.statista.com/statistics/1249474/india-gsk-pharmaceuticals-csr-expenditure/